Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

MUCOSAL IMMUNOLOGY

Get the IL-17F outta here!

A Publisher Correction to this article was published on 01 February 2019

This article has been updated

The cytokine IL-17F constrains the growth of immunoregulatory Clostridium cluster XIVa species and represents a potential therapeutic target for the treatment of inflammatory bowel disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Modulation of gut microbiota by IL-17F.

Marina Corral Spence/Springer Nature

Change history

  • 01 February 2019

    In the version of this article initially published, a word (“neutraling”) in sentence 2 of paragraph 5 is incorrect. The correct phrase is “...neutralizing properties...”. The error has been corrected in the HTML and PDF version of the article.

References

  1. Tang, C. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0134-y (2018).

  2. Ahern, P. P., Izcue, A., Maloy, K. J. & Powrie, F. Immunol. Rev. 226, 147–159 (2008).

    Article  Google Scholar 

  3. Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E. & Krueger, J. G. Trends Immunol. 34, 174–181 (2013).

    Article  CAS  Google Scholar 

  4. Targan, S. R. et al. Am. J. Gastroenterol. 111, 1599–1607 (2016).

    Article  CAS  Google Scholar 

  5. Hueber, W. et al. Gut 61, 1693–1700 (2012).

    Article  CAS  Google Scholar 

  6. Sands, B. E. et al. Gastroenterology 153, 77–86.e6 (2017).

    Article  CAS  Google Scholar 

  7. Feagan, B. G. et al. Lancet 389, 1699–1709 (2017).

    Article  CAS  Google Scholar 

  8. Maxwell, J. R. et al. Immunity 43, 739–750 (2015).

    Article  CAS  Google Scholar 

  9. Miossec, P. & Kolls, J. K. Nat. Rev. Drug Discov. 11, nrd3794 (2012).

    Article  Google Scholar 

  10. Atarashi, K. et al. Science 331, 337–341 (2011).

    Article  CAS  Google Scholar 

  11. Paramsothy, S. et al. J. Crohn’s Colitis 11, 1180–1199 (2017).

    Article  Google Scholar 

  12. Fuentes, S. et al. ISME J. 11, 1877–1889 (2017).

    Article  Google Scholar 

  13. Paramsothy, S. et al. Lancet 389, 1218–1228 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott E. Plevy.

Ethics declarations

Competing interests

A.O.H., J.E.T. and S.E.P. are employed by Janssen Pharmaceutical Companies of Johnson and Johnson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hall, A.O., Towne, J.E. & Plevy, S.E. Get the IL-17F outta here!. Nat Immunol 19, 648–650 (2018). https://doi.org/10.1038/s41590-018-0141-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-018-0141-z

This article is cited by

Search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology